Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that its board of directors has decided to abandon and cancel the reverse stock split that was previously approved by both the board and the company’s shareholders in February 2017.
Marijuana Investing
PotNetwork Holding, Inc. (POTN) Subsidiary Enhances Product Line
PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., has enhanced its product line with a selection of premium honey products.
Global Payout, Inc. (GOHE) Subsidiary Ramping-Up Sales and Marketing Efforts for PotSaver Brand
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., is currently in the process of ramping-up its sales and marketing efforts within Los Angeles County for its newly-acquired PotSaver brand.
India Globalization Capital, Inc. (NYSE: IGC) Enters MOU Related to Import and Distribution of Cannabinoid-Based Therapies in Germany
India Globalization Capital, Inc. (NYSE American: IGC) this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH.
Global Payout, Inc. (GOHE) Enters Final Stages of Audit in Preparation for Uplisting to OTCQB Venture Marketplace
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it is in the final stages of performing a two-year audit in an effort to become a fully reporting SEC company.
Global Payout, Inc. (GOHE) Subsidiary Teams with Pegasus Fintech, Inc. to Develop Cryptocurrency-Based Token
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has established a strategic partnership with Pegasus Fintech, Inc.
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
EVIO, Inc. (OTCQB: EVIO) this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017.
India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided compelling in vitro data
InMed Provides Updates On Cannabinoid-Based Drug Therapies For The Treatment Of Pain
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announced today additional pre-clinical results in the development of INM-405 for the treatment of pain.
Canopy Growth Applauds Action by TSX to Confirm That Listed Companies Should Not be Engaging in Federally Illegal US Cannabis Activities
TSX Staff Notice on Marijuana Validates Canopy's Longstanding Market Strategy to Protect Investors by Conducting Business Only Where it is Federally Legal to Do So; Should Bring Clarity and Relief to Investors Seeking to Participate in Listed and Compliant Cannabis Companies
PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter
PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain.
Global Payout, Inc. (GOHE) Subsidiary Makes Successful Showing at 2017 Southwest Cannabis Conference and Expo
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, in addition to its newly-acquired marketing and publishing entity, PotSaver, made a successful showing at last week’s Southwest Cannabis Conference and Expo in Phoenix, Arizona.
India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
Taking Stock of InMed - InMed President and CEO Eric Adams Sits Down For Two In-Depth Interviews
InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.